Hassett: White House may review AI models ‘like an FDA drug’ (opens in new tab)
National Economic Council Director Kevin Hassett said Wednesday the White House is considering an executive order that would require AI models to go through an evaluation process similar to that used by the Food and Drug Administration (FDA). The potential order comes as the Trump administration is grappling with Mythos, a new advanced AI model…
Read the original article